All lobbying filings
Akin Gump Strauss Hauer & Feld
Akin Gump Strauss Hauer & Feld filed a Q3 report for Genentech Inc. on October 20, 2026, reporting $50,000 in lobbying income.
Lobbying for Genentech Inc. · Biopharmaceutical company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Government bodies contacted
1
Lobbying activity
1
Issues related to public health preparedness; Issues related to access to drugs for minority communities; Issues related to healthcare education and screening.